FDA Approves First Targeted Drug for Bile Duct Cancer FDA Approves First Targeted Drug for Bile Duct Cancer

A subgroup of patients with advanced cholangiocarcinma who have tumors with FGFR2 abnormalities have a new treatment option -- the oral targeted therapy pemigatinib.News Alerts
Source: Medscape Medical News Headlines - Category: Consumer Health News Tags: Hematology-Oncology News Alert Source Type: news